An HIV model with age-structured latently infected cells

References

• N.M. Archin, N.K. Vaidya, J.D. Kuruc, A.L. Liberty, A. Wiegand, M.F. Kearney, M.S. Cohen, J.M. Coffin, R.J. Bosch, C.L. Gay, J.J. Eron, D.M. Margolis, and A.S. Perelson, Immediate antiviral therapy appears to restrict resting CD4+ cell HIV-1 infection without accelerating the decay of latent infection, Proc. Natl. Acad. Sci. USA 109 (2012), pp. 9523–9528.
   PubMed Web of Science ®Google Scholar
• H.T. Banks, K.B. Flores, S. Hu, E. Rosenberg, M. Buzon, X. Yu, and M. Lichterfeld, Immuno-modulatory strategies for reduction of HIV reservoir cells, J. Theoret. Biol. 372 (2015), pp. 146–158.
   PubMed Web of Science ®Google Scholar
• J.N. Blankson, D. Persaud, and R.F. Siliciano, The challenge of viral reservoirs in HIV-1 infection, Annu. Rev. Med. 53 (2002), pp. 557–593.
   PubMed Web of Science ®Google Scholar
• M. Bofill, G. Janossy, C.A. Lee, D. MacDonald-Burns, N. Phillips, C. Sabin, A. Timms, M.A. Johnson, and P.B. Kernoff, Laboratory control values for CD4 and CD8 T lymphocytes: Implications for HIV-1 diagnosis, Clin. Exp. Immunol. 88 (1992), pp. 243–252.
   PubMed Web of Science ®Google Scholar
• M.J. Buzón, M. Massanella, J.M. Llibre, A. Esteve, V. Dahl, M.C. Puertas, J.M. Gatell, P. Domingo, R. Paredes, M. Sharkey, S. Palmer, M. Stevenson, B. Clotet, Julià Blanco, and J. Martinez-Picado, HIV-1 replication and immune dynamics are affected by raltegravir intensification of HAART-suppressed subjects, Nat. Med. 16 (2010), pp. 460–465.
   PubMed Web of Science ®Google Scholar
• D.S. Callaway and A.S. Perelson, HIV-1 infection and low steady state viral loads, Bull. Math. Biol. 64 (2002), pp. 29–64.
   PubMed Web of Science ®Google Scholar
• N. Chomont, M. El-Far, P. Ancuta, L. Trautmann, F.A. Procopio, B. Yassine-Diab, G. Boucher, M.-R. Boulassel, G. Ghattas, J.M. Brenchley, T.W. Schacker, B.J. Hill, D.C. Douek, J.-P. Routy, E.K. Haddad, and R.-P. Sékaly, HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation, Nat. Med. 15 (2009), pp. 893–900.
   PubMed Web of Science ®Google Scholar
• T.W. Chun, J.S. Justement, S. Moir, C.W. Hallahan, J. Maenza, J.I. Mullins, A.C. Collier, L. Corey, and A.S. Fauci, Decay of the HIV reservoir in patients receiving antiretroviral therapy for extended periods: Implications for eradication of virus, J. Infect. Dis. 195 (2007), pp. 1762–1764.
   PubMed Web of Science ®Google Scholar
• J.M. Conway and D. Coombs, A stochastic model of latently infected cell reactivation and viral blip generation in treated HIV patients, PLoS Comput. Biol. 7 (2011), p. e1002033. 10.1371/journal.pcbi.1002033
   Google Scholar
• J.M. Conway and A.S. Perelson, Post-treatment control of HIV infection, Proc. Natl. Acad. Sci. USA 112 (2015), pp. 5467–5472.
   PubMed Web of Science ®Google Scholar
• R.T. Davey Jr., N. Bhat, C. Yoder, T.-W. Chun, J.A. Metcalf, R. Dewar, V. Natarajan, R.A. Lempicki, J.W. Adelsberger, K.D. Miller, J.A. Kovacs, M.A. Polis, R.E. Walker, J. Falloon, H. Masur, D. Gee, M. Baseler, D.S. Dimitrov, A.S. Fauci, and H.C. Lane, HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression, Proc. Natl. Acad. Sci. USA 96 (1999), pp. 15109–15114.
   PubMed Web of Science ®Google Scholar
• G. Doitsh, M. Cavrois, K.G. Lassen, O. Zepeda, Z. Yang, M.L. Santiago, A.M. Hebbeler, and W.C. Greene, Abortive HIV infection mediates CD4 T cell depletion and inflammation in human lymphoid tissue, Cell 143 (2010), pp. 789–801.
   PubMed Web of Science ®Google Scholar
• G. Doitsh, N.L. Galloway, X. Geng, Z. Yang, K.M. Monroe, O. Zepeda, P.W. Hunt, H. Hatano, S. Sowinski, I. Muñoz-Arias, and W.C. Greene, Cell death by pyroptosis drives CD4 T-cell depletion in HIV-1 infection, Nature 505 (2014), pp. 509–514.
   PubMed Web of Science ®Google Scholar
• Z. Feng, M. Iannelli, and F. Milner, A two-strain Tuberculosis model with age of infection, SIAM J. Appl. Math. 62 (2002), pp. 1634–1656.
   Web of Science ®Google Scholar
• D. Finzi, J. Blankson, J.D. Siliciano, J.B. Margolick, K. Chadwick, T. Pierson, K. Smith, J. Lisziewicz, F. Lori, C. Flexner, T.C. Quinn, R.E. Chaisson, E. Rosenberg, B. Walker, S. Gange, J. Gallant, and R.F. Siliciano, Latent infection of CD4t T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy, Nat. Med. 5 (1999), pp. 512–517.
   PubMed Web of Science ®Google Scholar
• J. Forde, J.M. Volpe, and S.M. Ciupe, Latently infected cell activation: A way to reduce the size of the HIV reservoir? Bull. Math. Biol. 74 (2012), pp. 1651–1672.
   PubMed Web of Science ®Google Scholar
• M.A. French, P. Price, and S.F. Stone, Immune restoration disease after antiretroviral therapy, AIDS 18 (2004), pp. 1615–1627.
   PubMed Web of Science ®Google Scholar
• R.T. Gandhi, L. Zheng, R.J. Bosch, E.S. Chan, D.M. Margolis, S. Read, B. Kallungal, S. Palmer, K. Medvik, M.M. Lederman, N. Alatrakchi, J.M. Jacobson, A. Wiegand, M. Kearney, J.M. Coffin, J.W. Mellors, and J.J. Eron, The effect of raltegravir intensification on low-level residual viremia in HIV-infected patients on antiretroviral therapy: A randomized controlled trial, PLoS Med. 7 (2010), p. e1000321.
   PubMed Web of Science ®Google Scholar
• J. Geginat, F. Sallusto, and A. Lanzavecchia, Cytokine-driven proliferation and differentiation of human naive, central memory, and effector memory CD4+ T cells, J. Exp. Med. 194 (2001), pp. 1711–1720.
   PubMed Web of Science ®Google Scholar
• S.A. Gourley and Y. Kuang, A stage structured predator-prey model and its dependence on maturation delay and death rate, J. Math. Biol. 49 (2004), pp. 188–200.
   PubMed Web of Science ®Google Scholar
• G. Gripenberg, S.-O. Londen, and O. Staffans, Volterra Integral and Functional Equations, Cambridge University Press, New York, 1990.
   Google Scholar
• H. Hatano, T.L. Hayes, V. Dahl, E. Sinclair, T.-H. Lee, R. Hoh, H. Lampiris, P.W. Hunt, S. Palmer, J.M. McCune, J.N. Martin, M.P. Busch, B.L. Shacklett, and S.G. Deeks, A randomized, controlled trial of raltegravir intensification in antiretroviral-treated, HIV-infected patients with a suboptimal CD4+ T cell response, J. Infect. Dis. 203 (2011), pp. 960–968.
   PubMed Web of Science ®Google Scholar
• H. Hatano, R. Scherzer, Y. Wu, K. Harvill, K. Maka, R. Hoh, E. Sinclair, S. Palmer, J.N. Martin, M.P. Busch, S.G. Deeks, and P.Y. Hsue, A randomized controlled trial assessing the effects of raltegravir intensification on endothelial function in treated HIV infection, J. Acquir. Immune. Defic. Syndr. 61 (2012), pp. 317–325.
   PubMed Web of Science ®Google Scholar
• L.E. Jones and A.S. Perelson, Transient viremia, plasma viral load, and reservoir replenishment in HIV-infected patients on antiretroviral therapy, J. Acquir. Immune. Defic. Syndr. 45 (2007), pp. 483–493.
   PubMed Web of Science ®Google Scholar
• H. Kim and A.S. Perelson, Viral and latent reservoir persistence in HIV-1-infected patients on therapy, PLoS Comput. Biol. 10 (2006), p. e135.
   Web of Science ®Google Scholar
• F. Lori, M.G. Lewis, J. Xu, G. Varga, D.E. JrZinn, C. Crabbs, W. Wagner, J. Greenhouse, P. Silvera, J. Yalley-Ogunro, C. Tinelli, and J. Lisziewicz, Control of SIV rebound through structured treatment interruptions during early infection, Science 290 (2000), pp. 1591–1593.
   PubMed Web of Science ®Google Scholar
• M. Markowitz, M. Louie, A. Hurley, E. Sun, M. Di Mascio, A.S. Perelson, and D.D. Ho, A novel antiviral intervention results in more accurate assessment of human immunodeficiency virus type 1 replication dynamics and T-cell decay in vivo, J. Virol. 77 (2003), pp. 5037–5038.
   PubMed Web of Science ®Google Scholar
• D. McMahon, J. Jones, A. Wiegand, S.J. Gange, M. Kearney, S. Palmer, S. McNulty, J.A. Metcalf, E. Acosta, C. Rehm, J.M. Coffin, J.W. Mellors, and F. Maldarelli, Short-course raltegravir intensification does not reduce persistent low-level viremia in patients with HIV-1 suppression during receipt of combination antiretroviral therapy, Clin. Infect. Dis. 50 (2000), pp. 912–919.
   Web of Science ®Google Scholar
• V. Muller, J.F. Vigueras-Gomez, and S. Bonhoeffer, Decelerating decay of latently infected cells during prolonged therapy for human immunodeficiency virus type 1 infection, J. Virol. 76 (2002), pp. 8963–8965.
   PubMed Web of Science ®Google Scholar
• S. Pankavich, The effects of latent infection on the dynamics of HIV, Differential Equations Dynam. Systems (2015), doi:doi:10.1007/s12591-014-0234-6.
   Web of Science ®Google Scholar
• A.S. Perelson and R.M. Ribeiro, Modeling the within-host dynamics of HIV infection, BMC Biol. 11 (2013), pp. 1–10.
   PubMed Web of Science ®Google Scholar
• A.S. Perelson, D.E. Kirschner, and R.J. De Boer, Dynamics of HIV infection of CD4+ T cells, Math. Biosci. 114 (1993), pp. 81–125.
   PubMed Web of Science ®Google Scholar
• A.S. Perelson, P. Essunger, Y. Cao, M. Vesanen, A. Hurley, K. Saksela, M. Markowitz, and D.D. Ho, Decay characteristics of HIV-1-infected compartments during combination therapy, Nature 387 (1997), pp. 188–191.
   PubMed Web of Science ®Google Scholar
• B. Ramratnam, S. Bonhoeffer, J. Binley, A. Hurley, L. Zhang, J.E. Mittler, M. Markowitz, J.P. Moore, A.S. Perelson, and D.D. Ho, Rapid production and clearance of HIV-1 and hepatitis C virus assessed by large volume plasma apheresis, Lancet 354 (1999), pp. 1782–1785.
   PubMed Web of Science ®Google Scholar
• B. Ramratnam, J.E. Mittler, L. Zhang, D. Boden, A. Hurley, F. Fang, C.A. Macken, A.S. Perelson, M. Markowitz, and D.D. Ho, The decay of the latent reservoir of replication-competent HIV-1 is inversely correlated with the extent of residual viral replication during prolonged anti-retroviral therapy, Nat. Med. 6 (2000), pp. 82–85.
   PubMed Web of Science ®Google Scholar
• L. Rong and A.S. Perelson, Modeling Latently infected cell activation: Viral and latent reservoir persistence, and viral blips in HIV-infected patients on potent therapy, PLoS Comput. Biol. 5 (2009), p. e1000533. doi:10.1371/journal.pcbi.1000533
   PubMed Web of Science ®Google Scholar
• L. Rong and A.S. Perelson, Modeling HIV persistence, the latent reservoir, and viral blips, J. Theoret. Biol. 260 (2009), pp. 308–331.
   PubMed Web of Science ®Google Scholar
• L. Rong and A.S. Perelson, Asymmetric division of activated latently infected cells may explain the decay kinetics of the HIV-1 latent reservoir and intermittent viral blips, Math. Biosci. 217 (2009), pp. 77–87.
   PubMed Web of Science ®Google Scholar
• L. Rong and A.S. Perelson, Mathematical analysis of multiscale models for hepatitis C virus dynamics under therapy with direct-acting antiviral agents, Math. Biosci. 245 (2013), pp. 22–30.
   PubMed Web of Science ®Google Scholar
• L. Rong, Z. Feng, and A.S. Perelson, Emergence of HIV-1 drug resistance during antiretroviral treatment, Bull. Math. Biol. 69 (2007), pp. 2027–2060.
   PubMed Web of Science ®Google Scholar
• L. Rong, Z. Feng, and A.S. Perelson, Mathematical analysis of age-structured HIV-1 dynamics with combination antiretroviral therapy, SIAM J. Appl. Math. 67 (2007), pp. 731–756.
   Web of Science ®Google Scholar
• A. Sáez-Cirión, C. Bacchus, L. Hocqueloux, V. Avettand-Fenoel, I. Girault, C. Lecuroux, V. Potard, P. Versmisse, A. Melard, T. Prazuck, B. Descours, J. Guergnon, J.-P. Viard, F. Boufassa, O. Lambotte, C. Goujard, L. Meyer, D. Costagliola, A. Venet, G. Pancino, B. Autran, C. Rouzioux, and J. Lifson, Post-treatment HIV-1 controllers with a long-term virological remission after the interruption of early initiated antiretroviral therapy ANRS VISCONTI Study, PLoS Pathog. 9 (2013), p. e1003211. doi:10.1371/journal.ppat.1003211
   PubMed Web of Science ®Google Scholar
• D. Sanchez-Taltavull and T. Alarcon, Stochastic modelling of viral blips in HIV-1-infected patients: Effects of inhomogeneous density fluctuations, J. Theoret. Biol. 371 (2015), pp. 79–89.
   PubMed Web of Science ®Google Scholar
• M. Shen, Y. Xiao, and L. Rong, Global stability of an infection-age structured HIV-1 model linking within-host and between-host dynamics, Math. Biosci. 263 (2015), pp. 37–50.
   PubMed Web of Science ®Google Scholar
• J.D. Siliciano and R.F. Siliciano, A long-term latent reservoir for HIV-1: Discovery and clinical implications, J. Antimicrob. Chemother. 54 (2004), pp. 6–9.
   PubMed Web of Science ®Google Scholar
• J.D. Siliciano, J. Kajdas, D. Finzi, T.C. Quinn, K. Chadwick, J.B. Margolick, C. Kovacs, S.J. Gange, and R.F. Siliciano, Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells, Nat. Med. 9 (2003), pp. 727–728.
   PubMed Web of Science ®Google Scholar
• M.C. Strain, H.F. Gunthard, D.V. Havlir, C.C. Ignacio, D.M. Smith, A.J. Leigh-Brown, T.R. Macaranas, R.Y. Lam, O.A. Daly, M. Fischer, M. Opravil, H. Levine, L. Bacheler, C.A. Spina, D.D. Richman, and J.K. Wong, Heterogeneous clearance rates of long-lived lymphocytes infected with HIV: Intrinsic stability predicts lifelong persistence, Proc. Natl. Acad. Sci. USA 100 (2003), pp. 4819–4824.
   PubMed Web of Science ®Google Scholar
• M.C. Strain, S.J. Little, E.S. Daar, D.V. Havlir, H.F. Günthard, R.Y. Lam, O.A. Daly, J. Nguyen, C.C. Ignacio, C.A. Spina, D.D. Richman, and J.K. Wong, Effect of treatment, during primary infection, on establishment and clearance of cellular reservoirs of HIV-1, J. Infect. Dis. 191 (2005), pp. 1410–1418.
   PubMed Web of Science ®Google Scholar
• H.R. Thieme and C. Castillo-Chavez, How may infection-age-dependent infectivity affect the dynamics of HIV/AIDS? SIAM J. Appl. Math. 53 (1993), pp. 1447–1479.
   Web of Science ®Google Scholar
• S. Wang and L. Rong, Stochastic population switch may explain the latent reservoir stability and intermittent viral blips in HIV patients on suppressive therapy, J. Theoret. Biol. 360 (2014), pp. 137–148.
   PubMed Web of Science ®Google Scholar
• S. Wang, P. Hottz, M. Schechter, and L. Rong, Modeling the slow CD4+ T cell decline in HIV-infected individuals, PLoS Comput. Biol. 11 (2015), p. e1004665. 10.1371/journal.pcbi.1004665
   Google Scholar
• X. Wang, G. Mink, D. Lin, X. Song, and L. Rong, Influence of raltegravir intensification on viral load and 2-LTR dynamics in HIV patients on suppressive antiretroviral therapy, J. Theoret. Biol., in review.
   Google Scholar
• S.A. Yukl, A.K. Shergill, K. McQuaid, S. Gianella, H. Lampiris, C.B. Hare, M. Pandori, E. Sinclair, H.F. Günthard, M. Fischer, J.K. Wong, and D.V. Havlir, Effect of raltegravir-containing intensification on HIV burden and T-cell activation in multiple gut sites of HIV-positive adults on suppressive antiretroviral therapy, AIDS 24 (2010), pp. 2451–2460.
   PubMed Web of Science ®Google Scholar
• L. Zhang, B. Ramratnam, K. Tenner-Racz, Y. He, M. Vesanen, S. Lewin, A. Talal, P. Racz, A.S. Perelson, B.T. Korber, M. Markowitz, Y. Guo, M. Duran, A. Hurley, J. Tsay, Y.-C. Huang, C.-C. Wang, and D.D. Ho, Quantifying residual HIV-1 replication in patients receiving combination antiretroviral therapy, N. Engl. J. Med. 340 (1999), pp. 1605–1613.
   PubMed Web of Science ®Google Scholar
• W. Zhang, L.M. Wahl, and P. Yu, Conditions for transient viremia in deterministic in-host models: Viral blips need no exogenous trigger, SIAM J. Appl. Math. 73 (2013), pp. 853–881.
   Web of Science ®Google Scholar